Untitled
Comparison of Action Potentials and Excitatory Postsynaptic Potentials (EPSPs)
- TABLE 7.4: Comparison of Action Potentials and Excitatory Postsynaptic Potentials (EPSPs)
Characteristics
Amplitude
- Action Potential: All-or-none response.
- EPSP: Graded response.
Stimulus for Opening of Ionic Gates
- Action Potential: Depolarization.
- EPSP: Acetylcholine (ACh) or other excitatory neurotransmitter.
Initial Effect of Stimulus
- Action Potential: Na+ channels open.
- EPSP: Common channels for Na+ and K+ open, leading to a loss of intracellular positive charges over time and distance.
Cause of Repolarization
- Action Potential: Opening of K+ gates.
- EPSP: Not applicable (graded potential).
Conduction Distance
- Action Potential: Regenerated over the length of the axon.
- EPSP: Typically 1 to 2 mm; considered a localized potential.
Positive Feedback Between Depolarization and Opening of Na+ Gates
- Action Potential: Yes.
- EPSP: No.
Maximum Depolarization
- Action Potential: +40 mV.
- EPSP: Close to zero.
Summation
- Action Potential: No summation; an all-or-none event.
- EPSP: Summation of EPSPs can produce graded depolarizations.
Refractory Period
- Action Potential: Yes.
- EPSP: No.
Effect of Drugs
- Action Potential: ACh effects inhibited by tetrodotoxin, not by curare.
- EPSP: ACh effects inhibited by curare, not by tetrodotoxin.
Mechanism of Depolarization
d-Gated Channels:
- Ligand-gated channels exemplified.
- Inward flow of Na+ ions depolarizes the cell, leading to the generation of an EPSP.
EPSP Characteristics:
- Occur in dendrites and cell bodies.
- Results from the binding of several ACh molecules that can add together to produce a greater depolarization (graded).
- This can potentially reach the threshold for voltage-gated channels located in the axon hillock, which can lead to the generation of an action potential.
Acetylcholinesterase (AChE)
- Definition: An enzyme responsible for inactivating ACh activity immediately after it binds to its receptor.
- Function: Hydrolyzes ACh into acetate and choline, which are then taken back into the presynaptic cell for reuse.
Cholinesterase Inhibitors
Overview: These drugs inhibit the action of acetylcholinesterase (AChE), leading to an increased amount of ACh in the synaptic cleft, thus enhancing cholinergic synaptic transmission.
Clinical AChE Inhibitors:
- Examples include neostigmine, physostigmine, and pyridostigmine, which are used in the treatment of myasthenia gravis and are significant in the treatment of Alzheimer's disease.
Nerve Gas:
- Mechanism: Inhibits AChE, causing spastic paralysis and potentially lethal overstimulation of cholinergic synapses.
G-Protein Coupled Receptors (GPCRs)
- Mechanism: The neurotransmitter receptor is coupled with the ion channel through a mechanism involving G-proteins.
- The binding at the receptor indirectly opens ion channels by utilizing a G-protein.
- Muscarinic ACh receptors operate through this mechanism, which affects ion channel functionality.